Biomedical Engineering Reference
In-Depth Information
10. Illum, L. 1998. Chitosan and its use as a pharmaceutical excipient. Pharm Res 15: 1326-1331.
11. van der Lubben, I. M., Verhoef, J. C., Borchard, G., and Junginger, H. E. 2001. Chitosan and its
derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci 14: 201-207.
12. Calvo, P., Remunan-Lopez, C., Vila-Jato, J. L., and Alonso, M. J. 1997. Novel hydrophilic chito-
san-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 16: 125-132.
13. Jameela, S. R., Kumary, T. V., Lal, A. V., and Jayakrishnan, A. 1998. Progesterone-loaded chito-
san microspheres: A long acting biodegradable controlled delivery system. J Control Release 52:
17-24.
14. van der Lubben, I. M., Verhoef, J. C., van Aelst, A. C., Borchard, G., and Junginger, H. E. 2001.
Chitosan microparticles for oral vaccination: Preparation, characterization and preliminary
in vivo uptake studies in murine Peyer's patches. Biomaterials 22: 687-694.
15. van der Lubben, I. M., Kersten, G., Fretz, M. M., Beuvery, C., Verhoef, J. C., and Junginger, H. E.
2003. Chitosan microparticles for mucosal vaccination against diphtheria: Oral and nasal effi-
cacy studies in mice. Vaccine 21: 1400-1408.
16. Li, X. Y., Jin, L. J., Uzonna, J. E., Li, S. Y., Liu, J. J., Li, H. Q., Lu, Y. N., Zhen, Y. H., and Xu, Y. P.
2009. Chitosan-alginate microcapsules for oral delivery of egg yolk immunoglobulin (IgY):
In vivo evaluation in a pig model of enteric colibacillosis. Vet Immuno Immunop 129: 132-136.
17. Kim, T. H., Jiang, H. L., Jere, D., Park, I. K., Cho, M. H., Nah, J. W., Choi, Y. J., Akaike, T., and
Cho, C. S. 2007. Chemical modification of chitosan as a gene carrier in vitro and in vivo. Prog
Polym Sci 32: 726-753.
18. Verma, I. M., and Somia, N. 1997. Gene therapy—Promises, problems and prospects. Nature
389: 239-242.
19. Munier, S., Messai, I., Delair, T., Verrier, B., and Ataman-Onal, Y. 2005. Cationic PLA nano-
particles for DNA delivery: Comparison of three surface polycations for DNA binding, pro-
tection and transfection properties. Colloids Surf B 43: 163-173.
20. Baker, A., Saltik M., Lehrmann, H., Killisch, I., Mautner, V., Lamm, G., Christofori, G., and
Cotten, M., 1997. Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for con-
densing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther 4: 773-782.
21. Byk, T., Haddada, H., Vainchenker, W., and Louache, F. 1998. Lipofectamine and related cat-
ionic lipids strongly improve adenoviral infection efficiency of primitive human hematopoietic
cells. Hum Gene Ther 9: 2493-2502.
22. Lew, D., Oarker, S. E., Latimer, T., Abai, A. M., Kuwahara-Rundell, A., Doh, S. G., Yang, Z. Y.,
Laface, D., Gromkowski, S. H., Nabel, G. J., Manthorpe, M., and Norman, J. 1995. Cancer gene
therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice.
Hum Gene Ther 6: 553-564.
23. Lee, K. Y., Kwon, I. C., Jo, W. H., and Jeong, S. Y. 2005. Complex formation between plasmid
DNA and self-aggregates of deoxycholic acid-modified chitosan. Polymer 46: 8107-8112.
24. Thanou, M., Florea, B. I., Geldof, M., Junginger, H. E., and Borchard, G. 2002. Quaternized chi-
tosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials 23: 153-159.
25. Thanou, M., Verhoef, J. C., and Junginger, H. E. 2001. Oral drug absorption enhancement by
chitosan and its derivatives. Adv Drug Deliv Rev 52 : 117-126.
26. Zhu, A. P., Fang, N., Chan-Park, M. B., and Chan, V. 2005. Interaction between
O-carboxymethylchitosan and dipalmitoyl- sn -glycero-3-phosphocholine bilayer. Biomaterials
26: 6873-6879.
27. Illum, L., Jabbal-Gill, I., Hinchcliffe, M., Fisher, A. N., and Davis, S. S. 2001. Chitosan as a novel
nasal delivery system for vaccines. Adv Drug Deliv Rev 51: 81-96.
28. Takeuchi, H., Yamamoto, H., Niwa, T., Hino, T., and Kawashima, Y. 1996. Enteral absorption of
insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res 13: 896-901.
29. Richardson, S. C. W., Kolbe, H. V. J., and Duncan, R. 1999. Potential of low molecular mass
chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex
and protect DNA. Int J Pharm 178: 231-243.
Search WWH ::




Custom Search